Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00317044 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

A Phase 2 study of Asthma and GERD, sponsored by AstraZeneca.

Completed
Registry status
Phase 2
Development phase
961
Enrollment target
20
Study locations

NCT00317044 is a Phase 2 study of Asthma and GERD that has completed, run by AstraZeneca. The registered enrollment target is 961 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00317044, a Phase 2 study of Asthma and GERD, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
Phase 2
Development phase
961 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine whether treatment with esomeprazole for 6 months will improve asthma in adult patients with moderate to severe asthma and symptoms of gastroesophageal reflux disease.

Conditions Studied

Asthma GERD

Interventions

  • DRUG Placebo
  • DRUG Esomeprazole

Study Locations (20)

Georgia

  • Research Site - Atlanta
  • Research Site - Stockbridge

Kansas

  • Research Site - Overland Park
  • Research Site - Wichita

Ohio

  • Research Site - Cincinnati
  • Research Site - Sylvania

Pennsylvania

  • Research Site - Pittsburgh
  • Research Site - Upland

Alabama

  • Research Site - Birmingham

Arizona

  • Research Site - Scottsdale

Arkansas

  • Research Site - Little Rock

California

  • Research Site - Fountain Valley

Trial Details

FieldValue
Enrollment Target 961 participants
Start Date 2006-04
Est. Completion 2008-07
Phase Phase 2

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00317044

The ClinicalTrials.gov registry entry for NCT00317044 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 961 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00317044 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Georgia, Kansas, Ohio.

Frequently Asked Questions

What is clinical trial NCT00317044 about?

NCT00317044 is a clinical study titled "Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma". The purpose of this study is to determine whether treatment with esomeprazole for 6 months will improve asthma in adult patients with moderate to severe asthma and symptoms of gastroesophageal reflux disease.

What is the current status of trial NCT00317044?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 961 participants. The study started on 2006-04. Estimated completion is 2008-07.

What conditions does trial NCT00317044 study?

This clinical trial studies the following conditions: Asthma, GERD.

What interventions are being tested in trial NCT00317044?

The interventions under investigation include: Placebo (DRUG), Esomeprazole (DRUG).

Who is sponsoring clinical trial NCT00317044?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00317044 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

GERD

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.